Epilepsy Clinical Trials in Phoenix

Showing 81-100 of 115 trials

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

NCT01118949

The purpose is to assess the safety of Lacosamide in subjects with uncontrolled Primary Generalized Tonic-Clonic (PGTC) seizures with Idiopathic Generalized Epilepsy.

Epilepsy

UCB BIOSCIENCES, Inc.49 participantsStarted May 2010

Alabaster, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +22 more locations

COMPLETEDPhase 3< 1 mile

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

NCT00655486

The purpose of this study is to allow eligible subjects from the parent study, SP925 \[NCT00655551\] to continue lacosamide and to obtain additional long-term safety data

Partial EpilepsiesPartial Onset Seizures

UCB BIOSCIENCES, Inc.97 participantsStarted Apr 2008

Phoenix, Arizona, United States • Baltimore, Maryland, United States • Chesterfield, Missouri, United States +4 more locations

Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy

Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset Seizures

Epilepsy Trials in Other Cities

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

Bioequivalency Study of Levetiracetam 750 mg Tablets Under Fed Conditions

Study to Assess the Safety and Tolerability of Intravenous Carbamazepine in Adults With Epilepsy

A Pharmacokinetic Study of a Single-Dose of Diazepam Nasal Spray in Adult Epileptic Patients Experiencing a Seizure Episode

Evaluation of Onfi Conversion Therapy Replacing Clonazepam in Patients With Medically Refractory Epilepsy

Lamotrigine Extended-Release In Elderly Patients With Epilepsy

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Study to Evaluate Serum Free Thyroxine (FT4) and Free Triiodothyronine (FT3) Measurements for Subjects Treated With Eslicarbazeine Acetate (ESL)

Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa

Pediatric Epilepsy Study in Subjects 1-24 Months

Lethargic Depression Study

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Radiosurgery or Open Surgery for Epilepsy Trial

Evaluation of Long-term Safety, and Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects With Epilepsy

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy

Other Conditions in Phoenix